


Precision medicine: Cap Digital and Medicen team up with Oncodesign, Servier and Intersystems

Vygon Group acquires 20 per cent of Canadian OxyNov

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102

EuMW 2018: ALPHA-RLH cluster showcases smaller footprint and improved performance microwave, wireless, radar and RF technologies

Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)

Inoviem Scientific enters into service-based partnership with XoNovo

Citoxlab signs investment and partnership deal with EPO

Citoxlab appoints Christophe Berthoux as CEO, Europe
